Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OMA1 is a zinc-dependent metalloprotease located in the inner mitochondrial membrane. It plays a central role in mitochondrial quality control, energy metabolism, and cellular stress responses. Under normal conditions, OMA1 remains largely inactive but is rapidly activated by various forms of mitochondrial stress such as loss of membrane potential or increased reactive oxygen species. Upon activation, it cleaves key substrates like OPA1, DELE1 and PINK1, modulating mitochondrial dynamics and initiating downstream signaling pathways involved in apoptosis and stress responses. Dysregulation of OMA1 activity has been implicated in diseases like ALS, heart failure, neurodegenerative disorders, and cancer.
Proteolytic cleavage of target proteins (OPA1, DELE1, PINK1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial protease OMA1.